Fundacion Para la Investigacion de Malaga en Biomedicina y Salud

Fundacion Para la Investigacion de Malaga en Biomedicina y Salud is a research organisation in Malaga, Spain that has taken part in 29 EU-funded projects since 2008, receiving €6.4M in EU funding and leading 13 as coordinator.

EU funding received€6.4M
EU projects29
As coordinator13
Running now21
First EU project2008
Latest project2027
CountrySpain
EU registration (PIC)998029218
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Fundacion Para la Investigacion de Malaga en Biomedicina y Salud's own share of each project, not the project's full budget.

  • Horizon Europe€4.6M · 17 projects
  • FP7 (2007 to 2013)€763k · 2 projects
  • Horizon 2020€588k · 4 projects
  • EU4Health Programme (EU4H)€435k · 5 projects
  • 3rd Health Programme€3k · 1 project

Projects

29 EU-funded projects, newest first. Fundacion Para la Investigacion de Malaga en Biomedicina y Salud led 13 of them as coordinator. Each links to the official record.

  • IRMCoordinator

    Glutaminase Isoenzymes: Gatekeepers of Bioenergetics, Immunity, and Tumor Microenvironment in Diabetes-Induced Hepatocellular Carcinoma

    Horizon Europe · 2027–2029 · Project on CORDIS ↗

    €210ktheir share
  • Triple-RCoordinator

    Identification of long non-coding RNA-based biomarkers of immunotherapy response in Triple-Negative Breast Cancer via liquid biopsy profiling

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €210ktheir share
  • PHOENIXAssociated partner

    Phase I/II trial of an Oral ER-stress iNducer in relapsed/refractory neuroblastoma and paediatric solid tumours

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

  • CELL-NANO-REMOTECoordinator

    Remote control of multiple cell functions through multi-stimuli-responsive nanoparticle assemblies

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €1.7Mtheir share
  • ECHOAssociated partner

    Empowering and Connecting Diverse Communities for Multi-Hazard Resilience with Open Data, Open Models, and Open-Source Software

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • GRADIENTCoordinator

    Impact of gut microbiota targeted dietary intervention on obesity: A precision medicine approach

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €181ktheir share
  • CARABELA-NF1Coordinator

    CARABELA-NF1: CDK4/6i Resistance and Biomarker Analysis in Neoadjuvant settings from CARABELA trial.

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €194ktheir share
  • MORBIUSCoordinator

    Cure for Miniature Brittle Bones: Treatment of Osteogenesis ImpeRfecta patient-derived Bone organoids with Innovative AAV-mediated Ultimate Gene-editing System

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €226ktheir share
  • ClimAIrAssociated partner

    Climate change and air contamination: Artificial Intelligence applied on the correlation between air pollutants and non-communicable respiratory diseases in Europe

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • BRECISEAssociated partner

    Biomarker Research and Evaluation for Clinical Implementation and Supporting Systems Enhancement

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • JAREDAssociated partner

    Joint Action on REspiratory Diseases

    EU4Health Programme (EU4H) · 2024–2027 · Project on the EU portal ↗

    €137ktheir share
  • Project-COMFORTPartner

    Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €235ktheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €170ktheir share
  • ORACLECoordinator

    Optimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluation

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €1.4Mtheir share
  • ORTHO-ALLO-UNIONAssociated partner

    ORTHOpaedic treatment with ALLOgenic combined ATMP in long bone fracture delayed UNION and non-union (ORTHO-ALLO-UNION).

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • ProCureAssociated partner

    Public Procurement Assessment in the Healthcare Sector

    EU4Health Programme (EU4H) · 2023–2025 · Project on the EU portal ↗

    €86ktheir share
  • INTERACT-EUROPE 100Associated partner

    INTERACT-EUROPE 100

    EU4Health Programme (EU4H) · 2023–2026 · Project on the EU portal ↗

  • PROVIDEAssociated partner

    Prediction and prevention of cardiovascular diseases in pre- and type 2 diabetes

    EU4Health Programme (EU4H) · 2023–2027 · Project on the EU portal ↗

    €42ktheir share
  • LIVERATIONAssociated partner

    Unravelling the impact of Radiofrequency in liver surgery: the key to decrease local recurrence?

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • PRE-BITCoordinator

    Understanding the role of B cell phenotypes as a predictor of the efficacy and prognosis of allergen immunotherapy using allergic rhinitis to house dust mite as a model

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €185ktheir share
  • halt-RONINAssociated partner

    Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • ERA4HealthAssociated partner

    Fostering a European Research Area for Health Research

    Horizon Europe · 2022–2034 · Project on CORDIS ↗

  • ASSERTCoordinator

    Development of a nanotechnology-based innovative assay for the diagnosis of allergy to Betalactams

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €259ktheir share
  • 3TRAssociated partner

    Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

    Horizon 2020 · 2019–2028 · Project on CORDIS ↗

  • GAPPAssociated partner

    facilitatinG the Authorisation of Preparation Process for blood and tissues and cells

    3rd Health Programme · 2018–2022 · Project on the EU portal ↗

    €3ktheir share
  • IMMUNOMARKCoordinator

    Omics integration for precision cancer immunotherapy

    Horizon 2020 · 2018–2020 · Project on CORDIS ↗

    €170ktheir share
  • DIRECtACoordinator

    Targeting the Endocannabinoid System within Islets of Langerhans to Protect against Immune Destruction.

    Horizon 2020 · 2018–2020 · Project on CORDIS ↗

    €158ktheir share
  • DendrimmuneassaysCoordinator

    Development of sophisticated dendrimeric nanostructural materials with potential applications in drug allergy diagnosis: Towards immunoassays and cellular tests (basophil activation tests)

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €169ktheir share
  • REPROBESITYCoordinator

    Search for new therapeutic agents against complicated obesity by reprofiling existing drugs

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €594ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • air pollution engineering
  • allergology
  • antibiotics
  • arteriosclerosis
  • artificial intelligence
  • autoimmune diseases
  • bladder cancer
  • cardiovascular diseases
  • cell biology
  • cell metabolism
  • climate change adaptation
  • diabetes

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime